Figure 3
From: Enforced effect of tk-MCP-1 fusion gene in ovarian cancer
CD 25 of SKOV 3 /tk (20.00 ± 2.04%) and SKOV 3 /tk-MCP-1 (38.82 ± 2.48%) was obviously higher than SKOV 3 /neo (8.73 ± 1.65%) ( P < 0.05). CD25 of SKOV3/tk-MCP-1 was significantly higher than that of SKOV3/tk (P < 0.05). CD44v6 of SKOV3/tk (6.66 ± 2.01%) and SKOV3/tk-MCP-1 (6.51 ± 1.03%) was significantly lower than that of control group (40.74 ± 3.58%) (P < 0.01)